- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Influenza Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Influenza Therapeutics market size is estimated to be worth US$ 6836.6 million in 2021 and is forecast to a readjusted size of USD 9362.1 million by 2028 with a CAGR of 4.6% during review period. Hospitals accounting for % of the Influenza Therapeutics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Influenza Therapeutics include Abbott Laboratories, Astrazeneca PLC, Biocryst Pharmaceuticals, Inc., Chiron Corporation, and CSL Limited, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Influenza Therapeutics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Vaccines
Drugs
Market segment by Application, can be divided into
Hospitals
Clinic
Others
Market segment by players, this report covers
Abbott Laboratories
Astrazeneca PLC
Biocryst Pharmaceuticals, Inc.
Chiron Corporation
CSL Limited
Daiichi Sankyo Co., Ltd.
Glaxosmithkline PLC
Mitsubishi Tanabe Pharma Corporation
Nanotherapeutics Inc.
Protein Sciences Corporation
Roche Holding AG
Sanofi SA
Shionogi & Co., Ltd.
Sinovac Biotech Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Influenza Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Influenza Therapeutics, with revenue, gross margin and global market share of Influenza Therapeutics from 2019 to 2022.
Chapter 3, the Influenza Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Influenza Therapeutics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Influenza Therapeutics research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Influenza Therapeutics
1.2 Classification of Influenza Therapeutics by Type
1.2.1 Overview: Global Influenza Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Influenza Therapeutics Revenue Market Share by Type in 2021
1.2.3 Vaccines
1.2.4 Drugs
1.3 Global Influenza Therapeutics Market by Application
1.3.1 Overview: Global Influenza Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Global Influenza Therapeutics Market Size & Forecast
1.5 Global Influenza Therapeutics Market Size and Forecast by Region
1.5.1 Global Influenza Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Influenza Therapeutics Market Size by Region, (2017-2022)
1.5.3 North America Influenza Therapeutics Market Size and Prospect (2017-2028)
1.5.4 Europe Influenza Therapeutics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Influenza Therapeutics Market Size and Prospect (2017-2028)
1.5.6 South America Influenza Therapeutics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Influenza Therapeutics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Influenza Therapeutics Market Drivers
1.6.2 Influenza Therapeutics Market Restraints
1.6.3 Influenza Therapeutics Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Influenza Therapeutics Product and Solutions
2.1.4 Abbott Laboratories Influenza Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Astrazeneca PLC
2.2.1 Astrazeneca PLC Details
2.2.2 Astrazeneca PLC Major Business
2.2.3 Astrazeneca PLC Influenza Therapeutics Product and Solutions
2.2.4 Astrazeneca PLC Influenza Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Astrazeneca PLC Recent Developments and Future Plans
2.3 Biocryst Pharmaceuticals, Inc.
2.3.1 Biocryst Pharmaceuticals, Inc. Details
2.3.2 Biocryst Pharmaceuticals, Inc. Major Business
2.3.3 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product and Solutions
2.3.4 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Biocryst Pharmaceuticals, Inc. Recent Developments and Future Plans
2.4 Chiron Corporation
2.4.1 Chiron Corporation Details
2.4.2 Chiron Corporation Major Business
2.4.3 Chiron Corporation Influenza Therapeutics Product and Solutions
2.4.4 Chiron Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Chiron Corporation Recent Developments and Future Plans
2.5 CSL Limited
2.5.1 CSL Limited Details
2.5.2 CSL Limited Major Business
2.5.3 CSL Limited Influenza Therapeutics Product and Solutions
2.5.4 CSL Limited Influenza Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 CSL Limited Recent Developments and Future Plans
2.6 Daiichi Sankyo Co., Ltd.
2.6.1 Daiichi Sankyo Co., Ltd. Details
2.6.2 Daiichi Sankyo Co., Ltd. Major Business
2.6.3 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product and Solutions
2.6.4 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Daiichi Sankyo Co., Ltd. Recent Developments and Future Plans
2.7 Glaxosmithkline PLC
2.7.1 Glaxosmithkline PLC Details
2.7.2 Glaxosmithkline PLC Major Business
2.7.3 Glaxosmithkline PLC Influenza Therapeutics Product and Solutions
2.7.4 Glaxosmithkline PLC Influenza Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Glaxosmithkline PLC Recent Developments and Future Plans
2.8 Mitsubishi Tanabe Pharma Corporation
2.8.1 Mitsubishi Tanabe Pharma Corporation Details
2.8.2 Mitsubishi Tanabe Pharma Corporation Major Business
2.8.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product and Solutions
2.8.4 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Mitsubishi Tanabe Pharma Corporation Recent Developments and Future Plans
2.9 Nanotherapeutics Inc.
2.9.1 Nanotherapeutics Inc. Details
2.9.2 Nanotherapeutics Inc. Major Business
2.9.3 Nanotherapeutics Inc. Influenza Therapeutics Product and Solutions
2.9.4 Nanotherapeutics Inc. Influenza Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Nanotherapeutics Inc. Recent Developments and Future Plans
2.10 Protein Sciences Corporation
2.10.1 Protein Sciences Corporation Details
2.10.2 Protein Sciences Corporation Major Business
2.10.3 Protein Sciences Corporation Influenza Therapeutics Product and Solutions
2.10.4 Protein Sciences Corporation Influenza Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Protein Sciences Corporation Recent Developments and Future Plans
2.11 Roche Holding AG
2.11.1 Roche Holding AG Details
2.11.2 Roche Holding AG Major Business
2.11.3 Roche Holding AG Influenza Therapeutics Product and Solutions
2.11.4 Roche Holding AG Influenza Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Roche Holding AG Recent Developments and Future Plans
2.12 Sanofi SA
2.12.1 Sanofi SA Details
2.12.2 Sanofi SA Major Business
2.12.3 Sanofi SA Influenza Therapeutics Product and Solutions
2.12.4 Sanofi SA Influenza Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Sanofi SA Recent Developments and Future Plans
2.13 Shionogi & Co., Ltd.
2.13.1 Shionogi & Co., Ltd. Details
2.13.2 Shionogi & Co., Ltd. Major Business
2.13.3 Shionogi & Co., Ltd. Influenza Therapeutics Product and Solutions
2.13.4 Shionogi & Co., Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Shionogi & Co., Ltd. Recent Developments and Future Plans
2.14 Sinovac Biotech Ltd.
2.14.1 Sinovac Biotech Ltd. Details
2.14.2 Sinovac Biotech Ltd. Major Business
2.14.3 Sinovac Biotech Ltd. Influenza Therapeutics Product and Solutions
2.14.4 Sinovac Biotech Ltd. Influenza Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Sinovac Biotech Ltd. Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Influenza Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Influenza Therapeutics Players Market Share in 2021
3.2.2 Top 10 Influenza Therapeutics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Influenza Therapeutics Players Head Office, Products and Services Provided
3.4 Influenza Therapeutics Mergers & Acquisitions
3.5 Influenza Therapeutics New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Influenza Therapeutics Revenue and Market Share by Type (2017-2022)
4.2 Global Influenza Therapeutics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Influenza Therapeutics Revenue Market Share by Application (2017-2022)
5.2 Global Influenza Therapeutics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Influenza Therapeutics Revenue by Type (2017-2028)
6.2 North America Influenza Therapeutics Revenue by Application (2017-2028)
6.3 North America Influenza Therapeutics Market Size by Country
6.3.1 North America Influenza Therapeutics Revenue by Country (2017-2028)
6.3.2 United States Influenza Therapeutics Market Size and Forecast (2017-2028)
6.3.3 Canada Influenza Therapeutics Market Size and Forecast (2017-2028)
6.3.4 Mexico Influenza Therapeutics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Influenza Therapeutics Revenue by Type (2017-2028)
7.2 Europe Influenza Therapeutics Revenue by Application (2017-2028)
7.3 Europe Influenza Therapeutics Market Size by Country
7.3.1 Europe Influenza Therapeutics Revenue by Country (2017-2028)
7.3.2 Germany Influenza Therapeutics Market Size and Forecast (2017-2028)
7.3.3 France Influenza Therapeutics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Influenza Therapeutics Market Size and Forecast (2017-2028)
7.3.5 Russia Influenza Therapeutics Market Size and Forecast (2017-2028)
7.3.6 Italy Influenza Therapeutics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Influenza Therapeutics Revenue by Type (2017-2028)
8.2 Asia-Pacific Influenza Therapeutics Revenue by Application (2017-2028)
8.3 Asia-Pacific Influenza Therapeutics Market Size by Region
8.3.1 Asia-Pacific Influenza Therapeutics Revenue by Region (2017-2028)
8.3.2 China Influenza Therapeutics Market Size and Forecast (2017-2028)
8.3.3 Japan Influenza Therapeutics Market Size and Forecast (2017-2028)
8.3.4 South Korea Influenza Therapeutics Market Size and Forecast (2017-2028)
8.3.5 India Influenza Therapeutics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Influenza Therapeutics Market Size and Forecast (2017-2028)
8.3.7 Australia Influenza Therapeutics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Influenza Therapeutics Revenue by Type (2017-2028)
9.2 South America Influenza Therapeutics Revenue by Application (2017-2028)
9.3 South America Influenza Therapeutics Market Size by Country
9.3.1 South America Influenza Therapeutics Revenue by Country (2017-2028)
9.3.2 Brazil Influenza Therapeutics Market Size and Forecast (2017-2028)
9.3.3 Argentina Influenza Therapeutics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Influenza Therapeutics Revenue by Type (2017-2028)
10.2 Middle East & Africa Influenza Therapeutics Revenue by Application (2017-2028)
10.3 Middle East & Africa Influenza Therapeutics Market Size by Country
10.3.1 Middle East & Africa Influenza Therapeutics Revenue by Country (2017-2028)
10.3.2 Turkey Influenza Therapeutics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Influenza Therapeutics Market Size and Forecast (2017-2028)
10.3.4 UAE Influenza Therapeutics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Influenza Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Influenza Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Influenza Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Influenza Therapeutics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Influenza Therapeutics Revenue Market Share by Region (2023-2028)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Influenza Therapeutics Product and Solutions
Table 9. Abbott Laboratories Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Astrazeneca PLC Corporate Information, Head Office, and Major Competitors
Table 11. Astrazeneca PLC Major Business
Table 12. Astrazeneca PLC Influenza Therapeutics Product and Solutions
Table 13. Astrazeneca PLC Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Biocryst Pharmaceuticals, Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Biocryst Pharmaceuticals, Inc. Major Business
Table 16. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product and Solutions
Table 17. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Chiron Corporation Corporate Information, Head Office, and Major Competitors
Table 19. Chiron Corporation Major Business
Table 20. Chiron Corporation Influenza Therapeutics Product and Solutions
Table 21. Chiron Corporation Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. CSL Limited Corporate Information, Head Office, and Major Competitors
Table 23. CSL Limited Major Business
Table 24. CSL Limited Influenza Therapeutics Product and Solutions
Table 25. CSL Limited Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Daiichi Sankyo Co., Ltd. Corporate Information, Head Office, and Major Competitors
Table 27. Daiichi Sankyo Co., Ltd. Major Business
Table 28. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product and Solutions
Table 29. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Glaxosmithkline PLC Corporate Information, Head Office, and Major Competitors
Table 31. Glaxosmithkline PLC Major Business
Table 32. Glaxosmithkline PLC Influenza Therapeutics Product and Solutions
Table 33. Glaxosmithkline PLC Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Mitsubishi Tanabe Pharma Corporation Corporate Information, Head Office, and Major Competitors
Table 35. Mitsubishi Tanabe Pharma Corporation Major Business
Table 36. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Product and Solutions
Table 37. Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Nanotherapeutics Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Nanotherapeutics Inc. Major Business
Table 40. Nanotherapeutics Inc. Influenza Therapeutics Product and Solutions
Table 41. Nanotherapeutics Inc. Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Protein Sciences Corporation Corporate Information, Head Office, and Major Competitors
Table 43. Protein Sciences Corporation Major Business
Table 44. Protein Sciences Corporation Influenza Therapeutics Product and Solutions
Table 45. Protein Sciences Corporation Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Roche Holding AG Corporate Information, Head Office, and Major Competitors
Table 47. Roche Holding AG Major Business
Table 48. Roche Holding AG Influenza Therapeutics Product and Solutions
Table 49. Roche Holding AG Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Sanofi SA Corporate Information, Head Office, and Major Competitors
Table 51. Sanofi SA Major Business
Table 52. Sanofi SA Influenza Therapeutics Product and Solutions
Table 53. Sanofi SA Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Shionogi & Co., Ltd. Corporate Information, Head Office, and Major Competitors
Table 55. Shionogi & Co., Ltd. Major Business
Table 56. Shionogi & Co., Ltd. Influenza Therapeutics Product and Solutions
Table 57. Shionogi & Co., Ltd. Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Sinovac Biotech Ltd. Corporate Information, Head Office, and Major Competitors
Table 59. Sinovac Biotech Ltd. Major Business
Table 60. Sinovac Biotech Ltd. Influenza Therapeutics Product and Solutions
Table 61. Sinovac Biotech Ltd. Influenza Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Global Influenza Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 63. Global Influenza Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 64. Breakdown of Influenza Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 65. Influenza Therapeutics Players Head Office, Products and Services Provided
Table 66. Influenza Therapeutics Mergers & Acquisitions in the Past Five Years
Table 67. Influenza Therapeutics New Entrants and Expansion Plans
Table 68. Global Influenza Therapeutics Revenue (USD Million) by Type (2017-2022)
Table 69. Global Influenza Therapeutics Revenue Share by Type (2017-2022)
Table 70. Global Influenza Therapeutics Revenue Forecast by Type (2023-2028)
Table 71. Global Influenza Therapeutics Revenue by Application (2017-2022)
Table 72. Global Influenza Therapeutics Revenue Forecast by Application (2023-2028)
Table 73. North America Influenza Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 74. North America Influenza Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 75. North America Influenza Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 76. North America Influenza Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 77. North America Influenza Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 78. North America Influenza Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 79. Europe Influenza Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 80. Europe Influenza Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 81. Europe Influenza Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 82. Europe Influenza Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 83. Europe Influenza Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 84. Europe Influenza Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 85. Asia-Pacific Influenza Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 86. Asia-Pacific Influenza Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 87. Asia-Pacific Influenza Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 88. Asia-Pacific Influenza Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 89. Asia-Pacific Influenza Therapeutics Revenue by Region (2017-2022) & (USD Million)
Table 90. Asia-Pacific Influenza Therapeutics Revenue by Region (2023-2028) & (USD Million)
Table 91. South America Influenza Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 92. South America Influenza Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 93. South America Influenza Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 94. South America Influenza Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 95. South America Influenza Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 96. South America Influenza Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 97. Middle East & Africa Influenza Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 98. Middle East & Africa Influenza Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 99. Middle East & Africa Influenza Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 100. Middle East & Africa Influenza Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 101. Middle East & Africa Influenza Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 102. Middle East & Africa Influenza Therapeutics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Influenza Therapeutics Picture
Figure 2. Global Influenza Therapeutics Revenue Market Share by Type in 2021
Figure 3. Vaccines
Figure 4. Drugs
Figure 5. Influenza Therapeutics Revenue Market Share by Application in 2021
Figure 6. Hospitals Picture
Figure 7. Clinic Picture
Figure 8. Others Picture
Figure 9. Global Influenza Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Influenza Therapeutics Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Influenza Therapeutics Revenue Market Share by Region (2017-2028)
Figure 12. Global Influenza Therapeutics Revenue Market Share by Region in 2021
Figure 13. North America Influenza Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Influenza Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Influenza Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Influenza Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Influenza Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Influenza Therapeutics Market Drivers
Figure 19. Influenza Therapeutics Market Restraints
Figure 20. Influenza Therapeutics Market Trends
Figure 21. Abbott Laboratories Recent Developments and Future Plans
Figure 22. Astrazeneca PLC Recent Developments and Future Plans
Figure 23. Biocryst Pharmaceuticals, Inc. Recent Developments and Future Plans
Figure 24. Chiron Corporation Recent Developments and Future Plans
Figure 25. CSL Limited Recent Developments and Future Plans
Figure 26. Daiichi Sankyo Co., Ltd. Recent Developments and Future Plans
Figure 27. Glaxosmithkline PLC Recent Developments and Future Plans
Figure 28. Mitsubishi Tanabe Pharma Corporation Recent Developments and Future Plans
Figure 29. Nanotherapeutics Inc. Recent Developments and Future Plans
Figure 30. Protein Sciences Corporation Recent Developments and Future Plans
Figure 31. Roche Holding AG Recent Developments and Future Plans
Figure 32. Sanofi SA Recent Developments and Future Plans
Figure 33. Shionogi & Co., Ltd. Recent Developments and Future Plans
Figure 34. Sinovac Biotech Ltd. Recent Developments and Future Plans
Figure 35. Global Influenza Therapeutics Revenue Share by Players in 2021
Figure 36. Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 37. Global Top 3 Players Influenza Therapeutics Revenue Market Share in 2021
Figure 38. Global Top 10 Players Influenza Therapeutics Revenue Market Share in 2021
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 40. Global Influenza Therapeutics Revenue Share by Type in 2021
Figure 41. Global Influenza Therapeutics Market Share Forecast by Type (2023-2028)
Figure 42. Global Influenza Therapeutics Revenue Share by Application in 2021
Figure 43. Global Influenza Therapeutics Market Share Forecast by Application (2023-2028)
Figure 44. North America Influenza Therapeutics Sales Market Share by Type (2017-2028)
Figure 45. North America Influenza Therapeutics Sales Market Share by Application (2017-2028)
Figure 46. North America Influenza Therapeutics Revenue Market Share by Country (2017-2028)
Figure 47. United States Influenza Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Influenza Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Influenza Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Influenza Therapeutics Sales Market Share by Type (2017-2028)
Figure 51. Europe Influenza Therapeutics Sales Market Share by Application (2017-2028)
Figure 52. Europe Influenza Therapeutics Revenue Market Share by Country (2017-2028)
Figure 53. Germany Influenza Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Influenza Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Influenza Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Influenza Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Influenza Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Influenza Therapeutics Sales Market Share by Type (2017-2028)
Figure 59. Asia-Pacific Influenza Therapeutics Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Influenza Therapeutics Revenue Market Share by Region (2017-2028)
Figure 61. China Influenza Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Influenza Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South Korea Influenza Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Influenza Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Influenza Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Influenza Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Influenza Therapeutics Sales Market Share by Type (2017-2028)
Figure 68. South America Influenza Therapeutics Sales Market Share by Application (2017-2028)
Figure 69. South America Influenza Therapeutics Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Influenza Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Influenza Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East and Africa Influenza Therapeutics Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Influenza Therapeutics Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Influenza Therapeutics Revenue Market Share by Country (2017-2028)
Figure 75. Turkey Influenza Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Influenza Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. UAE Influenza Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
